Published in AIDS Res Hum Retroviruses on February 01, 1995
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol (1997) 3.77
Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol (1998) 2.94
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol (1997) 2.46
Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol (2009) 2.37
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J Virol (2000) 1.94
Eradicating HIV-1 infection: seeking to clear a persistent pathogen. Nat Rev Microbiol (2014) 1.65
R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models. PLoS One (2010) 1.29
Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx). J Virol (2006) 1.13
Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain. J Virol (2003) 1.10
Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J Virol (1998) 1.07
Simian herpesviruses and their risk to humans. Vaccine (2010) 1.02
Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia. J Virol (1998) 0.82
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)). J Virol (2001) 0.76
An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 5.03
Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature (1986) 4.35
Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med (1999) 3.86
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Wildfire responses to abrupt climate change in North America. Proc Natl Acad Sci U S A (2009) 3.34
SIV adaptation to human cells. Nature (1989) 3.09
Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science (1996) 2.65
Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet Pathol (1988) 2.50
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A (1997) 2.34
Brief report: infection of a laboratory worker with simian immunodeficiency virus. N Engl J Med (1994) 2.32
Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J Virol (2000) 2.26
Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol (1995) 2.01
Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol (1997) 1.86
Murine leukemia virus long terminal repeat sequences can enhance gene activity in a cell-type-specific manner. Mol Cell Biol (1985) 1.81
Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia. J Infect Dis (1988) 1.75
Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol (1997) 1.63
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology (2001) 1.52
Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol (2002) 1.46
Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol (1995) 1.39
Epstein-Barr virus-related herpesvirus from a rhesus monkey (Macaca mulatta) with malignant lymphoma. Int J Cancer (1986) 1.38
Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J Virol (1998) 1.38
Studies on the secretory immunologic system of fowl. 3. Serum and secretory IgA of the chicken. J Immunol (1973) 1.37
Pre-operative oral carbohydrate loading in colorectal surgery: a randomized controlled trial. Colorectal Dis (2006) 1.36
Effects of initiation of 3'-azido,3'-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J Infect Dis (1993) 1.35
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30
Transmissible lymphoma and simian acquired immunodeficiency syndrome in rhesus monkeys. J Natl Cancer Inst (1986) 1.23
Efficacy of SIV/deltaB670 glycoprotein-enriched and glycoprotein-depleted subunit vaccines in protecting against infection and disease in rhesus monkeys. AIDS (1991) 1.23
Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann Neurol (1988) 1.22
Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. AIDS Res Hum Retroviruses (1998) 1.20
Epidemiology of rob beta-lactamase among ampicillin-resistant Haemophilus influenzae isolates in the United States. J Infect Dis (1988) 1.19
Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann Surg (1996) 1.17
Evolution of a simian immunodeficiency virus pathogen. J Virol (1998) 1.15
AIDS vaccine developments. Nature (1992) 1.15
Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys. Folia Parasitol (Praha) (1994) 1.15
The replicative capacity of rhesus macaque peripheral blood mononuclear cells for simian immunodeficiency virus in vitro is predictive of the rate of progression to AIDS in vivo. J Gen Virol (2000) 1.12
Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J Immunol (2000) 1.12
Targeted integration of baboon endogenous virus in the BEVI locus on human chromosome 6. Nature (1983) 1.11
Thymus in simian immunodeficiency virus-infected rhesus monkeys. Lab Invest (1991) 1.10
Serial pathogenesis study of SIV brain infection. J Med Primatol (1991) 1.10
Experimental leprosy in three species of monkeys. Science (1985) 1.09
SIV/DeltaB670 transmission across oral, colonic, and vaginal mucosae in the macaque. J Med Primatol (1997) 1.07
Structure and function of serum and membrane immunoglobulin D (IgD). Contemp Top Mol Immunol (1978) 1.06
Lentivirus-induced pulmonary lesions in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus. Vet Pathol (1991) 1.05
Immunodeficiency and lymphoproliferative disease in an African green monkey dually infected with SIV and STLV-I. AIDS Res Hum Retroviruses (1992) 1.04
Correlates of SIV encephalitis in rhesus monkeys. J Med Primatol (1992) 1.03
Depression of lymphocyte responses to mitogens in mangabeys with disseminated experimental leprosy. Cell Immunol (1985) 1.03
Lymphocyte surface IgD and IgM in non-human primates. Int Arch Allergy Appl Immunol (1976) 1.00
Oral transmission of primate lentiviruses. J Infect Dis (1999) 0.99
Functional analysis of monkey lymphocyte subsets defined by OKT4 and OKT8 Monoclonal Antibodies. Cell Immunol (1983) 0.99
Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J Virol (1994) 0.99
Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution. J Virol (1998) 0.98
Chromatographic fractionation of rhesus monkey (Macaca mulatta) IgG subclasses using deae cellulose and protein A-sepharose. J Immunol Methods (1982) 0.97
Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol Cell Biol (1997) 0.96
In vitro ethanol suppresses alveolar macrophage TNF-alpha during simian immunodeficiency virus infection. Am J Respir Crit Care Med (2000) 0.95
Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J Med Primatol (1996) 0.95
Genotypic analysis of infant macaques infected transplacentally and orally. J Med Primatol (1996) 0.94
Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res Hum Retroviruses (2000) 0.93
Herpesvirus saimiri-induced malignant lymphoma in rabbits. J Natl Cancer Inst (1976) 0.92
Simian AIDS-associated lymphoma in rhesus and cynomolgus monkeys recapitulates the primary pathobiological features of AIDS-associated non-Hodgkin's lymphoma. AIDS Res Hum Retroviruses (1999) 0.92
Oral SIV, SHIV, and HIV type 1 infection. AIDS Res Hum Retroviruses (1998) 0.92
IgM-forming cells as the immediate precursor of IgA-producing cells during ontogeny of the immunoglobulin-producing system of the chicken. J Immunol (1974) 0.92
Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during early, middle, and late gestation. J Med Primatol (1990) 0.91
Neonatal disease induced by SIV infection of the rhesus monkey (Macaca mulatta). AIDS Res Hum Retroviruses (1993) 0.91
Immunology of pyelonephritis in the primate model: live versus heat-killed bacteria. Kidney Int (1981) 0.91
Secretory immunological system of fowl. V. The gallbladder: an integral part of the secretory immunological system of fowl. Int Arch Allergy Appl Immunol (1976) 0.91
A model for the maturation of protective antibody responses to SIV envelope proteins in experimentally immunized monkeys. J Med Primatol (1997) 0.91
Squamous epithelial proliferative lesions associated with rhesus Epstein-Barr virus in simian immunodeficiency virus-infected rhesus monkeys. J Infect Dis (1995) 0.90
Rhesus rhadinovirus infection in healthy and SIV-infected macaques at Tulane National Primate Research Center. J Med Primatol (2003) 0.90
Identification of SIV env-specific CTL in the jejunal mucosa in vaginally exposed, seronegative rhesus macaques (Macaca mulatta). J Med Primatol (2000) 0.90
Experimental leprosy in monkeys. I. Sooty mangabey monkeys: transmission, susceptibility, clinical and pathological findings. Lepr Rev (1995) 0.90
Rhesus lymphocryptovirus infection during the progression of SAIDS and SAIDS-associated lymphoma in the rhesus macaque. AIDS Res Hum Retroviruses (2000) 0.90
Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus. Am J Pathol (1998) 0.89